Wf. Mcguirt et al., FLOOR OF MOUTH CARCINOMA - THE MANAGEMENT OF THE CLINICALLY NEGATIVE NECK, Archives of otolaryngology, head & neck surgery, 121(3), 1995, pp. 278-282
Objectives: Examine the management of the clinically negative neck and
evaluate the role of elective neck dissection in patients with squamo
us carcinoma of the floor of the mouth. Design: Retrospective analysis
of a cohort of patients with squamous carcinoma of the floor of the m
outh and NO stage disease of the neck who were treated between 1973 an
d 1992. The mean follow-up was 6 years. Patients: The cohort consisted
of 129 patients. Excluded from analysis were patients without evidenc
e of disease but less than 3 years of follow-up and those with uncerta
in resection margins. Intervention: Resection of the floor of the mout
h lesion with or without marginal mandibulectomy. Elective lymph-adene
ctomy was performed in 26 (23%) of the 129 patients. Outcome Measure:
Estimates were obtained of survival according to mode of therapy, clas
sification of treatment modality, determinate cure, locoregional failu
re, salvage, and occult disease by clinical stage. Results: Occult dis
ease was detected in 23% of the patients who underwent elective neck d
issection. Recurrence in the neck occurred in 36% of 103 patients who
received follow-up but did not undergo elective neck dissection. The d
eterminate survival at 3 years was 100% for patients with occult disea
se who underwent elective neck dissection. Overall, 96% of the patient
s who were treated with elective neck dissection were cured; 85% of th
e patients who received no initial treatment of the neck were cured; a
nd 59% of the patients with failure in the neck were salvaged. Conclus
ions: A more aggressive approach to the neck with NO disease may be wa
rranted. Selective neck dissection allows early removal of occult meta
stases with acceptable morbidity. In elective dissection for clinicall
y and histologically negative necks, the high rate of survival may res
ult from the removal of metastatic carcinoma that was missed in the hi
stopathologic sampling process.